1 September 2020 - 31 August 2021
Parent institution: Leibniz Association
Subject/journal group: All
The table to the right includes counts of all research outputs for Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
|American Journal of Human Genetics||2||0.09|
|Journal of Biological Chemistry||2||0.58|
|Journal of Cell Biology||1||0.22|
|Journal of Neuroscience||1||0.01|
|Proceedings of the National Academy of Sciences of the United States of America||3||1.08|
Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.
Nonselective cation permeation in an AMPA-type glutamate receptor.
Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.
|The EMBO Journal||1||0.07|
|Earth & Environmental Sciences||1||0.05|
Top articles by Altmetric score in current window
Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.